Cargando…
Kickstarting Immunity in Cold Tumours: Localised Tumour Therapy Combinations With Immune Checkpoint Blockade
Cancer patients with low or absent pre-existing anti-tumour immunity (“cold” tumours) respond poorly to treatment with immune checkpoint inhibitors (ICPI). In order to render these patients susceptible to ICPI, initiation of de novo tumour-targeted immune responses is required. This involves trigger...
Autores principales: | Appleton, Elizabeth, Hassan, Jehanne, Chan Wah Hak, Charleen, Sivamanoharan, Nanna, Wilkins, Anna, Samson, Adel, Ono, Masahiro, Harrington, Kevin J., Melcher, Alan, Wennerberg, Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558396/ https://www.ncbi.nlm.nih.gov/pubmed/34733287 http://dx.doi.org/10.3389/fimmu.2021.754436 |
Ejemplares similares
-
Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy
por: Chan Wah Hak, Charleen M. L., et al.
Publicado: (2022) -
Kickstarter for dummies
por: Cebulski, Aimee
Publicado: (2013) -
CD4 T cell dynamics shape the immune response to combination oncolytic herpes virus and BRAF inhibitor therapy for melanoma
por: Bozhanova, Galabina, et al.
Publicado: (2022) -
50 Activities to Kickstart Your Meetings
por: Thiagarajan, Sivasailam
Publicado: (2020) -
China kickstarts its vaccine market
por: Jia, Hepeng
Publicado: (2006)